// App-Quantinova.ai

LB.02.04 : EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE ( RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS )

Researchers

Presenter

  • Ott, C

Principal Investigators

  • Mahfoud, F

  • Mancia, G

  • Narkiewicz, K

  • Ruilope, L.M

  • Schlaich, M.P

  • Williams, B

  • Bhm, M

  • Schmieder, R.E

Medical Centers

  • Department of Nephrology and Hypertension, FAU Erlangen-Nürnberg, Erlangen, Germany

  • Universitatskliniken des Saarlandes, Klinik fur Innere Medizin III, Homburg/saar, Germany

  • Department of Medicine, University of Milano-Bicocca, St Gerardo Hospital, Monza, Italy

  • Medical University of Gdansk, Department Of Hypertension And Diabetology, Gdansk, Poland

  • Hypertension Unit, Department of Nephrology, Hospital de Octubre, Madrid, Spain

  • School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia

  • Institute of Cardiovascular Science, University College London, London, United Kingdom

Locations

  • Germany

  • Italy

  • Poland

  • Spain

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Observational

  • Multinational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved